Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2022-09-26 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
2022 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 INTERIM REPORT' and contains detailed sections including financial highlights, management discussion and analysis, condensed consolidated financial statements, and notes to the financial statements. It covers a six-month period ending June 30, 2022, which is typical for an interim or quarterly report. The content includes substantive financial data, analysis, and business highlights, indicating it is a comprehensive financial report for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-09-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not an announcement of a report publication but a substantive regulatory filing about share capital changes. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2022-09-23 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data. The content fits the category of 'Transaction in Own Shares' (POS), which covers company buybacks or sales of its own shares.
2022-09-22 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed information on repurchases of shares, dates, prices, and confirmations that these repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the stock exchange. Therefore, it fits best under 'Transaction in Own Shares' (POS) category, which covers reports of the company buying back or selling its own shares.
2022-09-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed information on repurchases of shares, dates, prices, and confirmations of compliance with listing rules. The document is regulatory in nature, reporting share repurchase activity and capital changes, but it is not a full financial report, earnings release, or management discussion. It is a formal disclosure of share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length is over 10,000 characters, indicating it is a substantive disclosure rather than a brief announcement or certification. Therefore, the appropriate classification is POS with high confidence.
2022-09-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by Transcenta Holding Limited. It details repurchase of shares, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It fits the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and content confirm it is not a brief announcement or a certification but a detailed disclosure of share repurchase activity.
2022-09-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.